Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 2/20 | 0.57 |
| ▸ | PAM | P19021 | 1/20 | 0.57 |
| ▸ | MMP1 | P03956 | 1/20 | 0.56 |
| ▸ | MMP2 | P08253 | 1/20 | 0.56 |
| ▸ | MMP9 | P14780 | 1/20 | 0.56 |
| ▸ | MMP12 | P39900 | 1/20 | 0.56 |
| ▸ | CACNA1B | Q00975 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | MAPT | P10636 | 2/20 | 0.48 |
| ▸ | RECQL | P46063 | 2/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | MAOB | P27338 | 1/20 | 0.47 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.47 |
| ▸ | TNKS | O95271 | 1/20 | 0.47 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.47 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.47 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.47 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3324115 | 1.00 | IDO1 (0.57) | IDO1PAMMMP1MMP2MMP9 | |
| SCHEMBL9762368 | 0.88 | IDO1 (0.57) | IDO1PAMMMP1MMP2MMP9 | |
| SCHEMBL293067 | 0.88 | IDO1 (0.57) | IDO1PAMMMP1MMP2MMP9 | |
| SCHEMBL9595673 | 0.86 | MMP1 (0.55) | IDO1PAMMMP1MMP2MMP9 | |
| SCHEMBL9595675 | 0.86 | MMP1 (0.55) | IDO1PAMMMP1MMP2MMP9 | |
| SCHEMBL113959 | 0.85 | IDO1 (0.58) | IDO1PAMMMP1MMP2MMP9 | |
| SCHEMBL9762373 | 0.85 | MMP1 (0.54) | IDO1PAMMMP1MMP2MMP9 | |
| SCHEMBL29600 | 0.85 | MMP1 (0.54) | IDO1PAMMMP1MMP2MMP9 | |
| SCHEMBL3295683 | 0.85 | MMP1 (0.54) | IDO1PAMMMP1MMP2MMP9 | |
| SCHEMBL12123424 | 0.85 | MMP1 (0.54) | IDO1PAMMMP1MMP2MMP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 216 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116265438-B | Synthesis method of 5-HT6 receptor molecule based on C-N-axis indole olefin axial chirality | 南京理工大学 | 2024-10-29 | — | — | CN | claimed |
| CN-116286185-A | Sweet essence for heating cigarettes, tobacco sheet and heating cigarettes | 河南中烟工业有限责任公司 | 2023-06-23 | — | — | CN | claimed |
| CN-116265438-A | Synthesis method of 5-HT6 receptor molecule based on C-N-axis indole olefin axial chirality | 南京理工大学 | 2023-06-20 | — | — | CN | claimed |
| CN-111440071-B | Perilla alcohol cinnamyl alcohol carbonate spice | 北京工商大学 | 2022-01-25 | — | — | CN | claimed |
| EP-2727915-B1 | Synthesis of deuterated catechols and benzo[d][1,3]dioxoles and derivatives thereof | CONCERT PHARMACEUTICALS INC (US) | 2016-04-13 | — | — | EP | claimed |
| EP-2727915-A1 | Synthesis of deuterated catechols and benzo[d][1,3]dioxoles and derivatives thereof | Concert Pharmaceuticals Inc. (US) | 2014-05-07 | — | — | EP | claimed |
| US-4889894-A | Compatible polymer mixtures | ROHM GMBH (DE) | 1989-12-26 | — | — | US | claimed |
| EP-4676937-A1 | METHODS OF SYNTHESIZING FLUORINATED MACROCYCLES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2026-01-14 | — | — | EP | disclosed |
| EP-4419513-B1 | ANTITUMORAL COMPOUNDS | PHARMA MAR SA (ES) | 2025-08-27 | — | — | EP | disclosed |
| US-12384800-B2 | Antitumoral compounds | PHARMA MAR, S.A. (ES) | 2025-08-12 | — | — | US | disclosed |
| US-20250243174-A1 | ANTITUMORAL COMPOUNDS | PHARMA MAR, S.A. (ES) | 2025-07-31 | — | — | US | disclosed |
| WO-2025077996-A1 | SYNTHETIC PROCESS FOR THE MANUFACTURE OF ECTEINASCIDIN COMPOUNDS | PHARMA MAR, S.A. (ES) | 2025-04-17 | — | — | WO | disclosed |
| WO-2025050647-A1 | IONIZABLE CATIONIC LIPID COMPOUNDS AS WELL AS PREPARATION METHOD THEREFOR AND USE THEREOF | 晟迪生物医药(苏州)有限公司 | 2025-03-13 | — | — | WO | disclosed |
| EP-0301401-B1 | LEUKOTRIENE ANTAGONISTS, PROCESS FOR THEIR PREPARATION, THEIR USE IN THE TREATMENT OF ILLNESSES | HOECHST AKTIENGESELLSCHAFT (DE) | 1991-11-27 | — | — | EP | disclosed |
| US-5023123-A | Molding materials | ROHM GMBH (DE) | 1991-06-11 | — | — | US | disclosed |
| US-4889894-A | Compatible polymer mixtures | ROHM GMBH (DE) | 1989-12-26 | — | — | US | disclosed |
| US-4851440-A | ASTHMA | HOECHST AKTIENGESELLSCHAFT (DE) | 1989-07-25 | — | — | US | disclosed |
| EP-0260923-A2 | Temperature sensing composition | MEDICAL INDICATORS (a limited partnership under US law) (US) | 1988-03-23 | — | — | EP | disclosed |
| EP-0257419-A1 | Process for the preparation of antibacterial 7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene derivatives | HOECHST AKTIENGESELLSCHAFT (DE) | 1988-03-02 | — | — | EP | disclosed |
| US-4330665-A | Process for the preparation of aromatic polycarbonates | BAYER AKTIENGESELLSCHAFT (DE) | 1982-05-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12384800-B2 | Antitumoral compounds | TP53, TOP1, MCL1 | IDO1 2586/4885PAM 3233/4885MMP1 1985/4885 |
| US-20250243174-A1 | ANTITUMORAL COMPOUNDS | MCL1, XPOT, GZMB | IDO1 1908/4885PAM 2007/4885MMP1 3028/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.